Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Rajani Katta, MD, on navigating the diet-skin connection: evidence, myths, and clinical ownership.

Diet and Dermatology: What to Say When Your Patients Ask

This SDPA interview with Steven Daveluy, MD, highlights integrative dermatology practices, acne strategies, and the value of supplements and dietary changes.

Can Supplements Help to Address Acne? With Steven Daveluy, MD

This Q&A interview with Gold at AAD 2026 highlights notable takeaways from his portion of the session titled 'Acne Boot Camp.'

Strategies and Technologies for Acne Treatment in 2026, With Michael H. Gold, MD

This interview from the Maui Derm 2026 conference features Lawrence Eichenfield, MD, discussing takeaways from his talk ‘Acne and Rosacea: Update 2026.’

Acne and Rosacea Treatment Updates for 2026, With Lawrence Eichenfield, MD

In this Q&A interview with Yeung, a discussion was conducted regarding newly-released findings on acne in patients identifying as transgender.

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

Investigators assessed the post-procedure reparative impact of a combination of vitamin C, E, and ferulic acid treatment in patients in China with atrophic acne scars.

Topical Antioxidant Serum May Be Effective in Treating Atrophic Acne Scars

Explore the evolving role of AI in dermatology, balancing its benefits with concerns over accuracy, bias, and the human touch in patient care.

AI in Dermatology: Discussing Downsides to the Adoption of Artificial Intelligence 

In this summary of coverage at the DERM 2025 conference, a list of notable stories highlighting acne management strategies is highlighted.

Advice on Systemic Therapy Use in Pediatric Acne, with Lisa Swanson, MD

These findings were announced by Sagimet Biosciences, showing that denifanstat met each of its primary and secondary endpoints in patients with acne.

New Phase 3 Data Suggest Denifanstat Effective for Moderate-to-Severe Acne

The HCPLive acne page is a resource for medical news and expert insights on dermatological disease. This page features expert-led coverage, articles, videos, and research on the therapies and development of treatments for chronic acne, and more.